While we’re enjoying the last days of summer, many signs of fall are already here: the UC Davis campus buzzing with staff and ...

CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for ...

On Five Live, the discussion centers on the science of longevity and the potential for humans to live to 150. The programme ...

Investment risk is often defined in terms of volatility, but that framing is incomplete. Metrics like beta may identify stocks that have historically swung up or down more than the ...

A new generation of CRISPR technology developed at UNSW Sydney offers a safer path to treating genetic diseases like sickle cell, while also proving beyond doubt that chemical tags on DNA—often ...

Confectionery giant Mars Inc, has teamed up with biotechnology firm Pairwise, to develop more resilient cocoa, using CRISPR. CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a ...

CRISPR has taken the bioengineering world by storm since its first introduction. From treating sickle cell diseases to creating disease-resistant crops, the technology continues to boast success on ...

CRISPR gene-editing therapy has shown great potential to treat and even cure diseases, but scientists are now discovering how it can be used to prevent them as well. A team of researchers found a way ...

CRISPR is a gene-editing tool that acts like “molecular scissors,” but using it on cancer is complex. The technology’s biggest impact so far is in research labs, helping scientists understand how ...

CRISPR Therapeutics AG stock has surged nearly 90% since my Buy call in early May, reaching its highest value since February 2024. The rally builds on the historic approval of Casgevy, a gene editing ...